These effects, together with a preceding report exhibiting that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 guidance the concept of targeting ACKR3 as a singular technique to modulate the opioid procedure, which could open new therapeutic avenues for opioid-associated disorders. At that time, Microsoft Advertising and https://fredh504jih8.blogmazing.com/profile